Bioaffinity Technologies Stock Technical Analysis
| BIAF Stock | USD 1.26 0.04 3.08% |
As of the 28th of January, BioAffinity Technologies shows the Standard Deviation of 5.07, coefficient of variation of (486.57), and Risk Adjusted Performance of (0.14). bioAffinity Technologies technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm bioAffinity Technologies treynor ratio, as well as the relationship between the value at risk and skewness to decide if bioAffinity Technologies is priced correctly, providing market reflects its regular price of 1.26 per share. Given that BioAffinity Technologies is a hitting penny stock territory we recommend to closely look at its jensen alpha.
BioAffinity Technologies Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as BioAffinity, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to BioAffinityBioAffinity | Build AI portfolio with BioAffinity Stock |
BioAffinity Technologies Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 6.0 | Hold | 1 | Odds |
Most BioAffinity analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand BioAffinity stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of bioAffinity Technologies, talking to its executives and customers, or listening to BioAffinity conference calls.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioAffinity Technologies. If investors know BioAffinity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BioAffinity Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (13.83) | Revenue Per Share | Quarterly Revenue Growth (0.39) | Return On Assets | Return On Equity |
The market value of bioAffinity Technologies is measured differently than its book value, which is the value of BioAffinity that is recorded on the company's balance sheet. Investors also form their own opinion of BioAffinity Technologies' value that differs from its market value or its book value, called intrinsic value, which is BioAffinity Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioAffinity Technologies' market value can be influenced by many factors that don't directly affect BioAffinity Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BioAffinity Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if BioAffinity Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioAffinity Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
BioAffinity Technologies 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to BioAffinity Technologies' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of BioAffinity Technologies.
| 10/30/2025 |
| 01/28/2026 |
If you would invest 0.00 in BioAffinity Technologies on October 30, 2025 and sell it all today you would earn a total of 0.00 from holding bioAffinity Technologies or generate 0.0% return on investment in BioAffinity Technologies over 90 days. BioAffinity Technologies is related to or competes with Artelo Biosciences, GT Biopharma, Mobile Health, WORK Medical, Psyence Biomedical, Revelation Biosciences, and Protagenic Therapeutics. bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targete... More
BioAffinity Technologies Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure BioAffinity Technologies' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess bioAffinity Technologies upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.22) | |||
| Maximum Drawdown | 18.89 | |||
| Value At Risk | (9.13) | |||
| Potential Upside | 6.52 |
BioAffinity Technologies Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for BioAffinity Technologies' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as BioAffinity Technologies' standard deviation. In reality, there are many statistical measures that can use BioAffinity Technologies historical prices to predict the future BioAffinity Technologies' volatility.| Risk Adjusted Performance | (0.14) | |||
| Jensen Alpha | (1.12) | |||
| Total Risk Alpha | (1.53) | |||
| Treynor Ratio | (1.05) |
BioAffinity Technologies January 28, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.14) | |||
| Market Risk Adjusted Performance | (1.04) | |||
| Mean Deviation | 3.91 | |||
| Coefficient Of Variation | (486.57) | |||
| Standard Deviation | 5.07 | |||
| Variance | 25.75 | |||
| Information Ratio | (0.22) | |||
| Jensen Alpha | (1.12) | |||
| Total Risk Alpha | (1.53) | |||
| Treynor Ratio | (1.05) | |||
| Maximum Drawdown | 18.89 | |||
| Value At Risk | (9.13) | |||
| Potential Upside | 6.52 | |||
| Skewness | (0.07) | |||
| Kurtosis | 0.5957 |
bioAffinity Technologies Backtested Returns
bioAffinity Technologies secures Sharpe Ratio (or Efficiency) of -0.19, which signifies that the company had a -0.19 % return per unit of risk over the last 3 months. bioAffinity Technologies exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm BioAffinity Technologies' Coefficient Of Variation of (486.57), standard deviation of 5.07, and Risk Adjusted Performance of (0.14) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.0, which signifies a somewhat significant risk relative to the market. BioAffinity Technologies returns are very sensitive to returns on the market. As the market goes up or down, BioAffinity Technologies is expected to follow. At this point, bioAffinity Technologies has a negative expected return of -0.95%. Please make sure to confirm BioAffinity Technologies' treynor ratio, skewness, rate of daily change, as well as the relationship between the value at risk and accumulation distribution , to decide if bioAffinity Technologies performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.08 |
Very weak reverse predictability
bioAffinity Technologies has very weak reverse predictability. Overlapping area represents the amount of predictability between BioAffinity Technologies time series from 30th of October 2025 to 14th of December 2025 and 14th of December 2025 to 28th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of bioAffinity Technologies price movement. The serial correlation of -0.08 indicates that barely 8.0% of current BioAffinity Technologies price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.08 | |
| Spearman Rank Test | -0.15 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
BioAffinity Technologies technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
bioAffinity Technologies Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Normalized Average True Range is used to analyze tradable apportunities for bioAffinity Technologies across different markets.
About BioAffinity Technologies Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of bioAffinity Technologies on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of bioAffinity Technologies based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on bioAffinity Technologies price pattern first instead of the macroeconomic environment surrounding bioAffinity Technologies. By analyzing BioAffinity Technologies's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of BioAffinity Technologies's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to BioAffinity Technologies specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 | 2026 (projected) | Payables Turnover | 2.88 | 6.06 | 5.45 | 5.73 | Days Of Inventory On Hand | 3.88 | 1.68 | 1.94 | 1.84 |
BioAffinity Technologies January 28, 2026 Technical Indicators
Most technical analysis of BioAffinity help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for BioAffinity from various momentum indicators to cycle indicators. When you analyze BioAffinity charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.14) | |||
| Market Risk Adjusted Performance | (1.04) | |||
| Mean Deviation | 3.91 | |||
| Coefficient Of Variation | (486.57) | |||
| Standard Deviation | 5.07 | |||
| Variance | 25.75 | |||
| Information Ratio | (0.22) | |||
| Jensen Alpha | (1.12) | |||
| Total Risk Alpha | (1.53) | |||
| Treynor Ratio | (1.05) | |||
| Maximum Drawdown | 18.89 | |||
| Value At Risk | (9.13) | |||
| Potential Upside | 6.52 | |||
| Skewness | (0.07) | |||
| Kurtosis | 0.5957 |
BioAffinity Technologies January 28, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as BioAffinity stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 2,711 | ||
| Daily Balance Of Power | (0.50) | ||
| Rate Of Daily Change | 0.97 | ||
| Day Median Price | 1.29 | ||
| Day Typical Price | 1.28 | ||
| Price Action Indicator | (0.05) |
Complementary Tools for BioAffinity Stock analysis
When running BioAffinity Technologies' price analysis, check to measure BioAffinity Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioAffinity Technologies is operating at the current time. Most of BioAffinity Technologies' value examination focuses on studying past and present price action to predict the probability of BioAffinity Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioAffinity Technologies' price. Additionally, you may evaluate how the addition of BioAffinity Technologies to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |